These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38450758)

  • 1. R2R01: A long-acting single-chain peptide agonist of RXFP1 for renal and cardiovascular diseases.
    Poirier B; Pasquier O; Chenede X; Corbier A; Prigent P; Azam A; Bernard C; Guillotel M; Gillot F; Riva L; Briand V; Ingenito R; Gauzy-Lazo L; Duclos O; Philippo C; Maillere B; Bianchi E; Mallart S; Janiak P; Illiano S
    Br J Pharmacol; 2024 Jul; 181(13):1993-2011. PubMed ID: 38450758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models.
    Illiano S; Poirier B; Minoletti C; Pasquier O; Riva L; Chenede X; Menguy I; Guillotel M; Prigent P; Le Claire S; Gillot F; Thill G; Lo Presti F; Corbier A; Le Bail JC; Grailhe P; Monteagudo E; Ingenito R; Bianchi E; Philippo C; Duclos O; Mallart S; Bathgate R; Janiak P
    Sci Rep; 2022 Nov; 12(1):20435. PubMed ID: 36443381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases.
    Mallart S; Ingenito R; Bianchi E; Bresciani A; Esposito S; Gallo M; Magotti P; Monteagudo E; Orsatti L; Roversi D; Santoprete A; Tucci F; Veneziano M; Bartsch R; Boehm C; Brasseur D; Bruneau P; Corbier A; Froissant J; Gauzy-Lazo L; Gervat V; Marguet F; Menguy I; Minoletti C; Nicolas MF; Pasquier O; Poirier B; Raux A; Riva L; Janiak P; Strobel H; Duclos O; Illiano S
    J Med Chem; 2021 Feb; 64(4):2139-2150. PubMed ID: 33555858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
    Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
    J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists.
    Granberg KL; Sakamaki S; Fuchigami R; Niwa Y; Fujio M; Kato H; Bergström F; Larsson N; Persson M; Villar IC; Fujita T; Sugikawa E; Althage M; Yano N; Yokoyama Y; Kimura J; Lal M; Mochida H
    J Med Chem; 2024 Mar; 67(6):4442-4462. PubMed ID: 38502780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatment.
    Jelinic M; Leo CH; Post Uiterweer ED; Sandow SL; Gooi JH; Wlodek ME; Conrad KP; Parkington H; Tare M; Parry LJ
    FASEB J; 2014 Jan; 28(1):275-87. PubMed ID: 24036884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
    Hossain MA; Wade JD; Bathgate RA
    Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability.
    Hossain MA; Haugaard-Kedström LM; Rosengren KJ; Bathgate RA; Wade JD
    Org Biomol Chem; 2015 Nov; 13(44):10895-903. PubMed ID: 26368576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
    Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
    Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
    [No Abstract]   [Full Text] [Related]  

  • 12. Rh-relaxin-2 attenuates degranulation of mast cells by inhibiting NF-κB through PI3K-AKT/TNFAIP3 pathway in an experimental germinal matrix hemorrhage rat model.
    Li P; Zhao G; Chen F; Ding Y; Wang T; Liu S; Lu W; Xu W; Flores J; Ocak U; Zhang T; Zhang JH; Tang J
    J Neuroinflammation; 2020 Aug; 17(1):250. PubMed ID: 32859236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
    Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
    Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single chain peptide agonists of relaxin receptors.
    Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
    Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.
    Kern A; Bryant-Greenwood GD
    Endocrinology; 2009 May; 150(5):2419-28. PubMed ID: 19116340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
    Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
    Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
    Agoulnik AI; Agoulnik IU; Hu X; Marugan J
    Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure.
    Verdino P; Lee SL; Cooper FN; Cottle SR; Grealish PF; Hu CC; Meyer CM; Lin J; Copeland V; Porter G; Schroeder RL; Thompson TD; Porras LL; Dey A; Zhang HY; Beebe EC; Matkovich SJ; Coskun T; Balciunas AM; Ferrante A; Siegel R; Malherbe L; Bivi N; Paavola CD; Hansen RJ; Abernathy MM; Nwosu SO; Carr MC; Heuer JG; Wang X
    Br J Pharmacol; 2023 Aug; 180(15):1965-1980. PubMed ID: 36780899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.
    McBride A; Hoy AM; Bamford MJ; Mossakowska DE; Ruediger MP; Griggs J; Desai S; Simpson K; Caballero-Hernandez I; Iredale JP; Pell T; Aucott RL; Holmes DS; Webster SP; Fallowfield JA
    Sci Rep; 2017 Sep; 7(1):10806. PubMed ID: 28883402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.